UK: Drugs firm takes cost conscious doctors to court

The Independent – Independent experts have condemned the Swiss pharmaceuticals company Novartis for trying to force the NHS to buy an expensive drug to treat patients suffering from a degenerative eye disease, rather than using a cheaper, unlicensed alternative. Novartis is taking four NHS areas in the south of England to a judicial review because they have allowed doctors to prescribe the anti-cancer drug Avastin to treat the wet form of age-related macular degeneration. Read article

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>